BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » current events » Page 2

Mesenchymal Stem Cell Industry News Round Up | June 2015

June 22, 2015 By Cade Hildreth (CEO) Leave a Comment

Mesenchymal Stem Cell Current Events

The mesenchymal stem cell industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

While it may be possible to stay informed about mesenchymal stem cell industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant mesenchymal stem cell industry events for June 2015.

[Read more…]

Filed Under: MSCs, Stem Cells Tagged With: adipose-derived stem cells, Ampion, current events, cystic fibrosis, industry news, mesenchymal stem cells, osteoblasts, osteoporosis, Stemedica

Cord Blood Industry News Round-Up | June 2015

June 21, 2015 By Cade Hildreth (CEO) Leave a Comment

Cord Blood Industry News Round-Up | JUNE 2015

The cord blood banking industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

While it may be possible to stay informed about cord blood industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant cord blood industry events for June 2015.

[Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: Americord Registry, cord blood, Cord Blood Registry, current events, delayed cord clamping, industry news, SynGen, UCB, UCBT, umbilical cord blood transplantation

Cord Blood Industry News Round-Up | May 2015

May 28, 2015 By Cade Hildreth (CEO) Leave a Comment

Cord Blood Industry News May 2015

The cord blood banking industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

While it may be possible to stay informed about cord blood industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant cord blood industry events for May 2015. [Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: cord blood, Cord Blood America, Cord Blood Registry, Cryo-Cell, current events, hematopoietic stem cells, industry news, mesenchymal stem cells

Induced Pluripotent Stem Cell News Round-Up| February 15-22, 2015

February 20, 2015 By Cade Hildreth (CEO) Leave a Comment

iPSC News Round-Up February 2014

The induced pluripotent stem cell (iPSC) industry is a rapidly evolving area.  Since the discovery of iPSCs in 2006, there have been a number of important market events that have occurred, including the first ever clinical trial in humans that was initiated in August 2013 to investigate iPSC-derived cell sheets for restoring vision, as well as large funding awards, major initial public offerings (IPOs), critical patent challenges, and more. [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: cell therapy, current events, iPSC, market update, stem cells

Induced Pluripotent Stem Cell (iSPC) News Round-Up| January 2015

February 20, 2015 By Cade Hildreth (CEO) Leave a Comment

iPSC News Round-Up February 2014

The induced pluripotent stem cell (iPSC) industry is a rapidly evolving area.  Since the discovery of iPSCs in 2006, there have been a number of important market events that have occurred, including the first ever clinical trial in humans that was initiated in August 2013 to investigate iPSC-derived cell sheets for restoring vision, as well as large funding awards, major initial public offerings (IPOs), critical patent challenges, and more. [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: cell therapy, current events, iPSC

  • « Previous Page
  • 1
  • 2

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.